The CD4:CD8 ratio could serve as such a clinical biomarker in treated individuals.[9] Data on CD4:CD8 ratio recovery to normal levels (≥1) in children and young adults with perinatally acquired HIV infection are limited. The gene discussed is CD4; the disease is HIV infectious disease.